Peggs, Karl S <br/><br/>
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Jan 2011 
 - 49-57 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/ciq042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cytomegalovirus--immunology<br/>Cytomegalovirus Infections--immunology<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Interferon-gamma--metabolism<br/>Stem Cell Transplantation<br/>T-Lymphocytes--immunology<br/>Treatment Outcome